Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Granuloma, Plasma Cell × Crizotinib × Clear all

Phase

Phase 4 1 Phase 2/3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Lymphoid 1

Conditions

Lymphoma, Large-Cell, Anaplastic 2 Granuloma, Plasma Cell 1 Carcinoma, Non-Small-Cell Lung 1 ALK or ROS1-positive NSCLC 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05160922 2025-09-03

Crizotinib Continuation Clinical Study

Pfizer

Phase 4 Active not recruiting

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡